UNIGE document Scientific Article
previous document  unige:32409  next document
add to browser collection

Dépistage du cancer de la prostate: utilité, buts et perspectives en 2010

Jichlinski, Patrice
Published in Revue médicale suisse. 2010, vol. 6, no. 274, p. 2336-9
Abstract According to recent results of a sub-group of 20,000 patients from the ERSPC study, prostate cancer screening significantly increases disease specific survival for men with a life expectancy of 15 years. However presently, only 20% of prostate biopsies lead to the diagnosis of cancer. This low yield may be increased by using new tools on their way to validation, such as the blood and urinary markers p2-PSA and PCA3, so as MRI and tridimensional computerized echography. Finally, the tumours detected must be managed with subtlety, since a third of them are not overtly aggressive clinically. Hence, a significant proportion of such tumours may not need immediate curative intent treatment, and can be followed up in an active surveillance protocol.
Keywords HumansMaleMass Screening/methodsProstatic Neoplasms/diagnosis/prevention & control
PMID: 21290864
Full text
Article (Published version) (563 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-274-page-2336.htm
Research group Groupe Iselin Christophe (urologie) (106)
(ISO format)
ISELIN, Christophe, JICHLINSKI, Patrice. Dépistage du cancer de la prostate: utilité, buts et perspectives en 2010. In: Revue médicale suisse, 2010, vol. 6, n° 274, p. 2336-9. https://archive-ouverte.unige.ch/unige:32409

300 hits

0 download


Deposited on : 2013-12-18

Export document
Format :
Citation style :